# Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients

> **NCT03575520** · PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 63 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Pegfilgrastim
- **DRUG:** Doxorubicin/Cyclophosphamide(AC) treatment

## Key facts

- **NCT ID:** NCT03575520
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-07
- **Primary completion:** 2017-02-15
- **Final completion:** 2017-03-15
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2018-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03575520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03575520, "Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03575520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*